PeptideBase
Back to Database
evidence varies by claim

Larazotide

Larazotide

Other Named Peptides

Larazotide is indexed as peptide in the PeptideBase article library. It is referenced in “Peptides for Long COVID: What Is Being Studied—and What Is Only Being Marketed”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on Larazotide

Start here for the plain-English articles connected to this peptide.

immune_inflammatory12 min read

Peptides for Long COVID: What Is Being Studied—and What Is Only Being Marketed

No peptide is proven to treat Long COVID. Separate controlled trials of tirzepatide and larazotide from planned research, animal studies, anecdotes, and marketing.

Read article

Quick Facts

Origin
Named peptide referenced in PeptideBase coverage
Category
Other Named Peptides

Research Areas

immune_inflammatory

Tags

larazotideat1001peptidenamed peptide